Walleye Capital’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.1M Buy
183,075
+65,768
+56% +$5.13M 0.09% 286
2025
Q4
$9.26M Sell
117,307
-99,000
-46% -$8.57M 0.05% 712
2025
Q3
$19.8M Buy
216,307
+182,040
+531% +$14.8M 0.16% 254
2025
Q2
$2.24M Buy
34,267
+2,983
+10% +$194K 0.02% 1425
2025
Q1
$2.09M Sell
31,284
-40,725
-57% -$2.43M 0.02% 1383
2024
Q4
$3.98M Buy
+72,009
New +$4.13M 0.04% 1241
2024
Q3
Sell
-10,849
Closed -$691K 5231
2024
Q2
$691K Buy
+10,849
New +$704K 0.01% 3199
2023
Q4
Sell
-8,489
Closed -$493K 4937
2023
Q3
$493K Buy
+8,489
New +$490K 0.01% 2837
2020
Q3
Sell
-9,235
Closed -$299K 821
2020
Q2
$299K Buy
+9,235
New +$331K 0.07% 335
2020
Q1
Sell
-239
Closed -$15K 919
2019
Q4
$15K Sell
239
-10,663
-98% -$706K ﹤0.01% 1623
2019
Q3
$794K Buy
10,902
+7,246
+198% +$542K 0.52% 541
2019
Q2
$301K Buy
3,656
+3,036
+490% +$216K 0.29% 733
2019
Q1
$44K Buy
+620
New +$36.5K 0.06% 1235

Other funds holding ANIP